Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events
Jérôme Boursier, Hannes Hagström, Mattias Ekstedt et al. · Journal of Hepatology · 2022
Cited by 201 works. doi:10.1016/j.jhep.2021.12.031
Authors
References
- A Proportional Hazards Model for the Subdistribution of a Competing Risk
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
- Evaluating the Yield of Medical Tests
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- MissForest—non-parametric missing value imputation for mixed-type data
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
- Non-invasive evaluation of liver fibrosis using transient elastography